Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1C03XA01----[2] 67, 72
2Desmopressin[1] Desmopressin[2] D00291 ,
D02235 		[2] AVPR2,
F8 💬		[4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[5] 6, 64, 72, 225, 288
3Desmopressin intranasal[1] Desmopressin[2] D00291 ,
D02235 		[2] AVPR2,
F8 💬		[4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 72
4Desmopressin Oral Melt[1] Desmopressin[2] D00291 ,
D02235 		[2] AVPR2,
F8 💬		[4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 72
5Empagliflozin[1] Empagliflozin[1] D10459 [1] SLC5A2 💬-[5] 65, 72, 96, 97, 257
6Empagliflozin 25 MG[1] Empagliflozin[1] D10459 [1] SLC5A2 💬-[1] 72
7Empagliflozin 25mg[1] Empagliflozin[1] D10459 [1] SLC5A2 💬-[1] 72
8Empagliflozin 25mg Tbl[1] Empagliflozin[1] D10459 [1] SLC5A2 💬-[1] 72
9EXENATIDE[1] Exenatide[1] D04121 [1] GLP1R 💬[3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[6] 6, 17, 72, 78, 193, 233
10Experimental: CRH administration----[2] 72, 78
11Experimental: GLP1-RA (exenatide) administration[1] Exenatide[1] D04121 [1] GLP1R 💬[3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 72, 78
12IUPAC----[1] 72
13Other: Fluid Restriction----[1] 72
14Other: Induced hypotonic hyponatremia - SIAD model----[1] 72
15Oxytocin[1] Oxytocin[1] D00089 [1] OXTR 💬[4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬[6] 6, 72, 127, 193, 206, 226
16Oxytocin nasal spray[1] Oxytocin[1] D00089 [1] OXTR 💬[4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬[1] 72
17Samsca[1] Tolvaptan[1] D01213 [1] AVPR2 💬[3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[2] 67, 72
18SAMSCA*10CPR 15MG[1] Tolvaptan[1] D01213 [1] AVPR2 💬[3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 72
19Satavaptan[1] Satavaptan---[1] 72
20Satavaptan (SR121463)[1] Satavaptan---[1] 72
21Satavaptan (SR121463B)[1] Satavaptan---[1] 72
22SR121463B----[1] 72
23TOLVAPTAN[1] Tolvaptan[1] D01213 [1] AVPR2 💬[3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[3] 67, 72, 225
24Tolvaptan (SAMSCA)[1] Tolvaptan[1] D01213 [1] AVPR2 💬[3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 72
25Tolvaptan in euvolemic hyponatremia[1] Tolvaptan[1] D01213 [1] AVPR2 💬[3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 72
26Tolvaptan Oral Tablet[1] Tolvaptan[1] D01213 [1] AVPR2 💬[3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 72
27Urea[1] Urea[2] D00023 ,
D01749 		--[2] 72, 251